Literature DB >> 7843107

Protective effects of thiol compounds on chromate-induced toxicity in vitro and in vivo.

N Susa1, S Ueno, Y Furukawa.   

Abstract

The effects of thiol compounds (L-cysteine ethyl ester, 2,3-dimercaptosuccinic acid, or 2,3-dimercapto-1-propanesulfonic acid) on the toxicity induced by chromate (potassium dichromate) were investigated in HeLa cells and mice. Chromate-induced cytotoxicity evaluated by inhibition of cell growth and chromium content of the cells was diminished by all of the thiol compounds tested when the cells were incubated in the medium with both chromate and one of the thiol compounds. In mice injected ip with a thiol compound immediately after injection of chromate, mortality, ornithine carbamyl transferase activity in the serum, and chromium content in the liver were diminished remarkably compared with mice injected with chromate alone. These thiol compounds also caused an increase of urinary chromium excretion. These results suggest that the thiol compounds tested are useful for treating chromate-induced toxicity when they are given immediately after intake of the metal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7843107      PMCID: PMC1567400          DOI: 10.1289/ehp.94102s3247

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  8 in total

1.  Antagonists for acute oral cadmium chloride intoxication.

Authors:  M A Basinger; M M Jones; M A Holscher; W K Vaughn
Journal:  J Toxicol Environ Health       Date:  1988

2.  The tagging of red cells and plasma proteins with radioactive chromium.

Authors:  S J GRAY; K STERLING
Journal:  J Clin Invest       Date:  1950-12       Impact factor: 14.808

3.  Meso-dimercaptosuccinic acid, a chelating agent for the treatment of mercury poisoning.

Authors:  E Friedheim; C Corvi
Journal:  J Pharm Pharmacol       Date:  1975-08       Impact factor: 3.765

4.  Treatment of methylmercury poisoning in the rat with sodium 2,3-dimercaptopropane-i-sulfonate: influence of dose and mode of administration.

Authors:  B Gabard
Journal:  Toxicol Appl Pharmacol       Date:  1976-11       Impact factor: 4.219

5.  Effect of combined administration of DL-penicillamine and potassium dichromate on lethality, distribution and excretion of chromium in mice.

Authors:  N Susa; S Ueno; Y Furukawa; S Sunaga; Y Taruta; K Sato
Journal:  Kitasato Arch Exp Med       Date:  1988-04

6.  Antagonistic effect of DL-penicillamine of chromium toxicity in HeLa cells.

Authors:  N Susa
Journal:  Nihon Juigaku Zasshi       Date:  1984-02

7.  Oral cadmium chloride intoxication in mice: effects of penicillamine, dimercaptosuccinic acid and related compounds.

Authors:  O Andersen; J B Nielsen
Journal:  Pharmacol Toxicol       Date:  1988-11

8.  Sulfhydryl dependence in primary explant hematopoietic cells. Inhibition of growth in vitro with vitamin B12 compounds.

Authors:  J I Toohey
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

  8 in total
  3 in total

1.  Curcumin pretreatment prevents potassium dichromate-induced hepatotoxicity, oxidative stress, decreased respiratory complex I activity, and membrane permeability transition pore opening.

Authors:  Wylly Ramsés García-Niño; Edilia Tapia; Cecilia Zazueta; Zyanya Lucía Zatarain-Barrón; Rogelio Hernández-Pando; Claudia Cecilia Vega-García; José Pedraza-Chaverrí
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-17       Impact factor: 2.629

2.  Improvement of Experimentally Induced Hepatic and Renal Disorders in Rats using Lactic Acid Bacteria-fermented Soybean Extract (BiofermenticsTM).

Authors:  Ryoichi Shin; Momoyo Suzuki; Takeo Mizutani; Nobuyuki Susa
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-27       Impact factor: 2.629

Review 3.  Carcinogenicity of chromium and chemoprevention: a brief update.

Authors:  Yafei Wang; Hong Su; Yuanliang Gu; Xin Song; Jinshun Zhao
Journal:  Onco Targets Ther       Date:  2017-08-16       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.